Wang Justin, Hoffman Robert M, Ye Yin, Dillard Jordan, Barsky Sanford H
Scripps Mercy Hospital, MER 35, San Diego, CA 92103, USA.
AntiCancer, Inc., 7917 Ostow St., Suite B, San Diego, CA 92111, USA.
Lymphatics. 2024 Dec;2(4):195-211. doi: 10.3390/lymphatics2040016. Epub 2024 Oct 8.
Inflammatory breast cancer (IBC) is characterized by numerous tumor emboli within lymphatics. In a recent study, we observed tumor embolic budding both in vitro and in vivo within lymphovascular spaces and proposed this to account for the plethora of tumor emboli seen in IBC. These observations did not address, however, how lymphovascular invasion is initiated or the mechanisms involved. In the present study, using the well-characterized patient-derived xenograft (PDX), Mary-X, which exhibited florid lymphovascular invasion (LVI) in athymic mice (LVI) as defined by E-cadherin-positive tumor emboli within lymphatic channels distinguished by podoplanin and LYVE1 membrane and Prox1 nuclear immunoreactivities and spontaneous spheroidgenesis in vitro and human cases of IBC which showed similar LVI, we compared laser-captured microdissected emboli from Mary-X and from the cases of human IBC to non-embolic areas. Mary-X and IBC emboli expressed high levels of E-cadherin and no evidence of epithelial-mesenchymal transition (EMT). Mary-X spheroids expressed high levels of VEGF, especially VEGF-C, and stimulated both vascular and lymphatic endothelial haptotaxis. We then transplanted Mary-X serially into green, cyano, red, and nestin-green fluorescing protein (GFP-, CFP-, RFP-, and nestin-GFP) transgenic reporter mice in various combinations. Multicolor murine imaging studies indicated that reporter-labeled stroma initially encircled clumps of tumor cells and then served as a scaffold that supported nestin-GFP-labeled endothelial haptotaxis resulting in encircling lymphangiogenesis, confirmed by dual LYVE1 immunofluorescence. The present studies demonstrate a possible mechanism of a critical step of the tumor emboli formation of IBC.
炎性乳腺癌(IBC)的特征是淋巴管内存在大量肿瘤栓子。在最近的一项研究中,我们在体外和体内的淋巴管间隙中观察到肿瘤栓子出芽现象,并提出这可以解释IBC中大量肿瘤栓子的形成。然而,这些观察结果并未涉及淋巴管侵犯是如何启动的或其中涉及的机制。在本研究中,我们使用特征明确的患者来源异种移植瘤(PDX)Mary-X,该肿瘤在无胸腺小鼠中表现出活跃的淋巴管侵犯(LVI),其定义为淋巴管通道内E-钙黏蛋白阳性肿瘤栓子,通过血小板内皮细胞黏附分子-1和淋巴管内皮透明质酸受体-1膜及Prox1核免疫反应性来区分,并且在体外具有自发球状体形成能力,同时还有表现出类似LVI的人类IBC病例,我们将从Mary-X和人类IBC病例中通过激光捕获显微切割获得的栓子与非栓子区域进行比较。Mary-X和IBC栓子表达高水平的E-钙黏蛋白,且无上皮-间质转化(EMT)迹象。Mary-X球状体表达高水平的血管内皮生长因子(VEGF),尤其是VEGF-C,并刺激血管和淋巴管内皮细胞趋触性。然后,我们将Mary-X以各种组合方式连续移植到绿色、青色、红色和巢蛋白-绿色荧光蛋白(GFP-、CFP-、RFP-和巢蛋白-GFP)转基因报告小鼠体内。多色小鼠成像研究表明,报告基因标记的基质最初围绕肿瘤细胞团块,然后作为支架支持巢蛋白-GFP标记的内皮细胞趋触性,导致周围淋巴管生成,这通过双重LYVE1免疫荧光得以证实。本研究证明了IBC肿瘤栓子形成关键步骤的一种可能机制。